← Back to Search

Mindfulness Based Walking Therapy (MBWT) for Parkinson's Disease (MMR34 Trial)

N/A
Waitlist Available
Led By Kerri Rawson, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 weeks
Awards & highlights

Summary

This trial tests a new mindfulness-based walking program for people with Parkinson's disease who have trouble walking. The program aims to reduce stress and improve walking by using mindfulness techniques. Researchers will modify and test the program to ensure it is effective and easy to use. Mindfulness-based interventions are increasingly used for stress reduction and managing emotional states in Parkinson's disease patients.

Eligible Conditions
  • Parkinson's Disease
  • Freezing of Gait

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence: Average Percentage of Hours Participants Practiced Mindfulness at Home
Attendance of Participants: Average Percentage of Participants at Each Session
Recruitment of Sample: Number of Participants Recruited
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mindfulness Based Walking Therapy (MBWT)Experimental Treatment1 Intervention
Participants will participate in MBWT.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Walking Therapy (MBWT)
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,970 Previous Clinical Trials
2,308,614 Total Patients Enrolled
Kerri Rawson, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
24 Total Patients Enrolled
Gammon Earhart, PT, PhDPrincipal InvestigatorWashington University School of Medicine
~3 spots leftby Sep 2025